Spring Education Exchange (SEE): Day 1, Session 1
Presented By: Karen Kestenbaum, DNP, APN, CPHON
Session Details: Day 1: May 14, Session 1: 12:15 PM EST (11:15 AM CST/10:15 AM MST/9:15 AM PST)
Overview of the Session:
Blinatumomab, a bispecific T-cell engager (BITE), is a targeted immunotherapy used in treating pediatric B-cell acute lymphoblastic leukemia (ALL). With its indications recently expanding, more children are now receiving this innovative treatment. Blinatumomab presents unique side effects and requires specific administration protocols. As frontline caregivers, nurses must be equipped with knowledge about its special considerations, potential adverse reactions, and appropriate treatment strategies. Blinatumomab is becoming increasingly prevalent—where will it appear next
This session is designed to will ensure you are prepared for Blinatumomab’s evolving role in pediatric care.
Learning Outcomes:
- Understand the evolution of Blinatumomab in the treatment of pediatric B-ALL
- Analyze the nursing considerations when administering Blinatumomab
This contains 2 sections:
- Webinar Recording Link
- Post-Session Evaluation
Continuing Education Credit
APHON will provide 0.5 nursing continuing professional development (NCPD) contact hour(s) for the successful completion of this session. Successful completion requires attendance for the entire session and completion of the post-session evaluation.
Individual Learning Needs Assessment (ILNA) Coding
This program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 0.5 ILNA in one of the following categories:
- Care of the Pediatric Hem/Onc Patient
- Pediatric Hem/Onc Nursing Practice
- OR Professional Performance.
Please reach out to the Education Team at education@aphon.org with your name, the email associated with your APHON account, and the above ILNA category you would like to have reflected on your certificate. APHON can update your completion certificate to reflect your choice.
Spring Education Exchange (SEE) Access
The SEE session recordings and post-session evaluations will be available for all registered participants until June 19th (11:59 pm EST).
The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513.
None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies.
Questions or concerns? Contact education@aphon.org.
The APHON Spring Education Exchange is sponsored by ONCC.